Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 15, 2019

SELL
$77.85 - $96.01 $139,117 - $171,569
-1,787 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$88.91 - $98.84 $158,882 - $176,627
1,787 New
1,787 $169,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $292B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track American Beacon Advisors, Inc. Portfolio

Follow American Beacon Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Beacon Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American Beacon Advisors, Inc. with notifications on news.